Celebrating Women’s Contributions to Social Work
Highlighting key figures, milestones and movements that have shaped the profession
Highlighting key figures, milestones and movements that have shaped the profession
The phase 3 KeyVibe-010 study will discontinue the coformulation of pembrolizumab and vibostolimab treatment for high-risk melanoma due to futility.
Jean L. Koff, MD, MS, discusses key considerations in the choice of BTK inhibitors for frontline and maintenance treatment in MCL.
Ramez Kouzy, MD, discusses efforts to improve knowledge of the use of AI in radiation oncology through the creation of an online repository.
The 2024 ASTRO Annual Meeting will be held at the Walter E. Washington Convention Center, Washington, DC, and virtually September 29-October 2, 2024.
The SGO BRIDGES Research Initiative is a new, longitudinal clinical trials workshop for early career investigators with the aim of developing the next generation of…
Foundation Blog Unbreakable Spirit: Samantha’s Triumph Over Cervical Cancer Samantha’s journey with cervical cancer began unexpectedly at the age of 27. “You have cervical cancer,”…
A list of current (APEx®) facilities.
PJ DiPentino made the seven-hour trek from his home in Montana to Huntsman Cancer Institute. After receiving a warm welcome, he underwent bladder surgery and…
On October 31, 2023, pembrolizumab (Keytruda) was approved for use with gemcitabine/cisplatin in first-line treatment of patients with locally advanced unresectable or metastatic biliary…